Literature DB >> 15905505

Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo.

Michael A Brehm1, Keith A Daniels, John R Ortaldo, Raymond M Welsh.   

Abstract

Viral infections can strongly stimulate both NK cell and allospecific CD8 T cell responses, and these same effector cells can lyse allogeneic cell lines in vitro. However, the impact of viral infections on the effector systems mediating rejection of allogeneic tissues in vivo has not been fully explored. Using in vivo cytotoxicity assays, we evaluated the effector systems mediating the rejection of CFSE-labeled allogeneic splenocytes after an infection of C57BL/6 (B6) mice with lymphocytic choriomeningitis virus. Naive B6 mice predominantly used a NK cell-effector mechanism to reject allogeneic splenocytes because they rejected BALB/C (H2(d)) splenocytes but not CBA (H2(k)) splenocytes, and the rejection was prevented by immunodepletion of NK1.1(+) or Ly49D(+) NK cells. This rapid and efficient in vivo cytotoxicity assay recapitulated the specificity of NK cell-mediated rejection seen in longer duration in vivo assays. However, as early as 1 day after infection with lymphocytic choriomeningitis virus, a CD8 T cell-dependent mechanism participated in the rejection process and a broader range of tissue haplotypes (e.g., H2(k)) was susceptible. The CD8 T cell-mediated in vivo rejection process was vigorous at a time postinfection (day 3) when NK cell effector functions are peaking, indicating that the effector systems used in vivo differed from those observed with in vitro assays measuring the killing of allogeneic cells. This rapid generation of allospecific CTL activity during a viral infection preceded the peak of viral epitope-specific T cell responses, as detected by in vivo or in vitro cytotoxicity assays.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905505     DOI: 10.4049/jimmunol.174.11.6663

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  T-cell activation and transplantation tolerance.

Authors:  Bhavana Priyadharshini; Dale L Greiner; Michael A Brehm
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

2.  Rapid quantification of naive alloreactive T cells by TNF-alpha production and correlation with allograft rejection in mice.

Authors:  Michael A Brehm; Julie Mangada; Thomas G Markees; Todd Pearson; Keith A Daniels; Thomas B Thornley; Raymond M Welsh; Aldo A Rossini; Dale L Greiner
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

3.  Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance.

Authors:  Thomas B Thornley; Nancy E Phillips; Britte C Beaudette-Zlatanova; Thomas G Markees; Kapil Bahl; Michael A Brehm; Leonard D Shultz; Evelyn A Kurt-Jones; John P Mordes; Raymond M Welsh; Aldo A Rossini; Dale L Greiner
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

4.  Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses.

Authors:  Derek W Trobaugh; Liyan Yang; Francis A Ennis; Sharone Green
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

5.  Allografts stimulate cross-reactive virus-specific memory CD8 T cells with private specificity.

Authors:  M A Brehm; K A Daniels; B Priyadharshini; T B Thornley; D L Greiner; A A Rossini; R M Welsh
Journal:  Am J Transplant       Date:  2010-08       Impact factor: 8.086

6.  Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.

Authors:  Maria-Luisa del Rio; Nick D Jones; Leo Buhler; Paula Norris; Yasushi Shintani; Carl F Ware; Jose-Ignacio Rodriguez-Barbosa
Journal:  J Immunol       Date:  2012-04-06       Impact factor: 5.422

7.  The roles of CD8 central and effector memory T-cell subsets in allograft rejection.

Authors:  M H Oberbarnscheidt; Y-H Ng; G Chalasani
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

8.  Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity.

Authors:  Maria Cecilia Rodriguez-Galan; Della Reynolds; Silvia G Correa; Pablo Iribarren; Morihiro Watanabe; Howard A Young
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

9.  Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway.

Authors:  J A Graham; R A Wilkinson; T Hirohashi; C M Chase; R B Colvin; J C Madsen; J A Fishman; P S Russell
Journal:  Am J Transplant       Date:  2009-11       Impact factor: 8.086

10.  Murine neonates develop vigorous in vivo cytotoxic and Th1/Th2 responses upon exposure to low doses of NIMA-like alloantigens.

Authors:  Shannon J Opiela; Robert B Levy; Becky Adkins
Journal:  Blood       Date:  2008-06-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.